Surgery versus stereotactic radiotherapy for treatment of pulmonary metastases. A systematic review of literature.
It is not clear as to which is the best treatment among surgery and stereotactic radiotherapy (SBRT) for lung oligometastases. A systematic review of literature with a priori selection criteria was conducted on articles on the treatment of pulmonary metastases with surgery or SBRT. Only original articles with a population of patients of more than 50 were selected. After final selection, 61 articles on surgical treatment and 18 on SBRT were included. No difference was encountered in short-term survival between pulmonary metastasectomy and SBRT. In the long-term surgery seems to guarantee better survival rates. Mortality and morbidity after treatment are 0-4.7% and 0-23% for surgery, and 0-2% and 4-31% for SBRT. Surgical metastasectomy remains the treatment of choice for pulmonary oligometastases.
['Londero|Francesco|F|https://orcid.org/0000-0001-8955-6053', 'Grossi|William|W|https://orcid.org/0000-0003-1905-9099', 'Morelli|Angelo|A|', 'Parise|Orlando|O|', 'Masullo|Gianluca|G|', 'Tetta|Cecilia|C|https://orcid.org/0000-0001-6428-5592', 'Livi|Ugolino|U|', 'Maessen|Jos G|JG|', 'Gelsomino|Sandro|S|https://orcid.org/0000-0002-7746-989X']
surgery radiotherapy lung oligometastases oligorecurrence